Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial

By Potvin Stéphane   Stip Emmanuel   Lipp Olivier   Élie Robert   Mancini-Marië Adham   Demers Marie-France   Roy Marc-André   Bouchard Roch-Hugo   Gendron Alain  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1277-1285

Informa Healthcare

Access to resources Recommend Favorite

Implementation of integrated therapies for comorbid post‐traumatic stress disorder and substance use disorders in community substance abuse treatment programs

By  

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 3, 2015-05 ,pp. : 234-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders

By Kollins Scott H.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1345-1357

Informa Healthcare

Access to resources Recommend Favorite

Substance Use Disorders and Comorbid Mental Disorders in First-Time Admitted Patients from a Catchment Area

By  

European Addiction Research, Vol. 18, Iss. 1, 2011-10 ,pp. : 16-25

Karger

Access to resources Recommend Favorite

Social consequences of substance abuse: the impact of comorbid psychiatric disorders. A prospective study of a nation-wide sample of treatment-seeking patients

By Tómasson Kristinn   Vaglum Per  

Scandinavian Journal of Public Health, Vol. 26, Iss. 1, 1998-05 ,pp. : 63-70

Informa Healthcare

Access to resources Recommend Favorite